Pipeline
Product
Target
Indication
Commercial Rights
Preclinical
IND-Enabling
Phase l
Phase ll
Phase lll
-
RBD1007?
siRNA?
Caspase 2
NAION *
Global
Preclinical
IND-Enabling
Phase l
Phase ll
Phase lll
-
RBD8088?
(RiboOncoSTARTM)?
Undisclosed
Glioma
Global
Preclinical
IND-Enabling
Phase l
Phase ll
Phase lll
-
RBD8076
(RiboGalSTARTM)?
Undisclosed
HAE *
Global
Preclinical
IND-Enabling
Phase l
Phase ll
Phase lll
-
RBD4086/?
RBD1100?(RiboGalSTARTM)?
Undisclosed?
Inflammatory Diseases
Global
Preclinical
IND-Enabling
Phase l
Phase ll
Phase lll
* NAION: Non-Arteritic Anterior Ischemic Optic Neuropathy; HAE: Hereditary Angioedema.
